Vor Biopharma (VOR) Shares Issued (2020 - 2026)
Vor Biopharma (VOR) posted quarterly Shares Issued of $7.0 million for Q1 2026, up 134.8% year-over-year from $3.0 million in Q1 2025, and up 6.19% quarter-over-quarter from $6.6 million in Q4 2025.
Vor Biopharma (VOR) Shares Issued (2020 - 2026) Analysis & Trends
Vor Biopharma (VOR) has reported Shares Issued for 7 consecutive years, with $7.0 million the latest figure, recorded in Q1 2026.
- In Q1 2026, Shares Issued rose 134.8% year-over-year to $7.0 million; the TTM figure through Mar 2026 stood at $7.0 million (up 134.8% YoY), while the FY2025 annual figure was $6.6 million, up 1345.53% from the prior year.
- Shares Issued improved to $7.0 million in Q1 2026 per VOR's latest filing, from $6.6 million in the prior quarter.
- Across five years, Shares Issued topped out at $8.3 million in Q4 2023 and bottomed at $430011.0 in Q3 2022.
- Historically, Shares Issued has averaged $3.3 million across 5 years, with a median of $2.5 million in 2024.
- Annual changes were most pronounced in 2024 — Shares Issued plunged 94.49% — and 2025, when it surged 1345.53%.
- Vor Biopharma's Shares Issued stood at $6.5 million in 2022, then grew by 28.1% to $8.3 million in 2023, then slumped by 94.49% to $457152.0 in 2024, then soared by 1345.53% to $6.6 million in 2025, then climbed by 6.19% to $7.0 million in 2026.
- Business Quant data shows VOR's Shares Issued at $7.0 million in Q1 2026, $6.6 million in Q4 2025, and $1.7 million in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Shares Issued (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 128.13 Bn | 120.28 Bn | 2.84 Bn | - |
| 2 | Regeneron Pharmaceuticals | 112.33 Bn | 104.33 Bn | 3.93 Bn | - |
| 3 | Argenx Se | 53.24 Bn | 48.05 Bn | 1.41 Bn | - |
| 4 | Revolution Medicines | 43.64 Bn | 43.64 Bn | - | 18.36 Mn |
| 5 | BeOne Medicines | 39.27 Bn | 34.17 Bn | 1.53 Bn | - |
| 6 | MindWalk Holdings | 35.32 Bn | 35.31 Bn | 1.82 Bn | - |
| 7 | Royalty Pharma | 33.72 Bn | 35.84 Bn | - | - |
| 8 | Alnylam Pharmaceuticals | 30.58 Bn | 27.27 Bn | 992.69 Mn | - |
| 9 | Insmed | 27.01 Bn | 25.85 Bn | 358.27 Mn | - |
| 10 | Vor Biopharma | 1.36 Bn | 1.36 Bn | - | 7.55 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 7.55 Mn |
| Jun 30, 2026 | 7.55 Mn |
| Mar 31, 2026 | 7.02 Mn |
| Mar 31, 2026 | 7.02 Mn |
| Dec 31, 2025 | 6.61 Mn |
| Dec 31, 2025 | 6.61 Mn |
| Sep 30, 2025 | 1.74 Mn |
| Sep 30, 2025 | 1.74 Mn |
| Jun 30, 2025 | 7.51 Mn |
| Jun 30, 2025 | 7.51 Mn |
| Mar 31, 2025 | 2.99 Mn |
| Mar 31, 2025 | 2.99 Mn |
| Dec 31, 2024 | 457,152.00 |
| Dec 31, 2024 | 457,152.00 |
| Sep 30, 2024 | 2.46 Mn |
| Sep 30, 2024 | 2.46 Mn |
| Jun 30, 2024 | 1.89 Mn |
| Jun 30, 2024 | 1.89 Mn |
| Mar 31, 2024 | 3.13 Mn |
| Mar 31, 2024 | 3.13 Mn |